LRRK2 Antibodies

Santa Cruz Biotechnology features a diverse variety of LRRK2 monoclonal antibodies for research focused on understanding LRRK2's role in various cellular processes. Multiple detection methods are supported, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). LRRK2, or leucine-rich repeat kinase 2, plays a crucial role in neuronal function and has been linked to Parkinson's disease. The kinase activity of LRRK2 is essential for regulating cellular signaling pathways, and mutations in the LRRK2 gene are among the most common genetic causes of familial and sporadic forms of Parkinson's disease. Understanding LRRK2 function is vital for developing targeted therapies and advancing knowledge of neurodegenerative disorders. Researchers can explore LRRK2's involvement in cellular processes through various experimental approaches. LRRK2 monoclonal antibodies enable detailed investigation of protein localization, expression patterns, and interactions with other molecules. Current research utilizing LRRK2 monoclonal antibodies contributes significantly to advancing our understanding of neurodegenerative diseases and potential therapeutic strategies. Santa Cruz Biotechnology monoclonal antibodies support researchers worldwide in their mission to unlock new insights into neurological disorders and potential treatments.